Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 0.98%223.8M | 0.98%223.8M | -0.28%221.62M | -0.28%221.62M | -17.25%222.24M | -17.25%222.24M | 18.82%268.59M | 18.82%268.59M | 39.94%226.05M | 39.94%226.05M |
| -Cash and cash equivalents | 0.98%223.8M | 0.98%223.8M | -0.28%221.62M | -0.28%221.62M | -17.25%222.24M | -17.25%222.24M | 18.82%268.59M | 18.82%268.59M | 39.94%226.05M | 39.94%226.05M |
| Securities and investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15M | --15M |
| -Short term investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15M | --15M |
| Long term equity investment | 22.47%48.6M | 22.47%48.6M | 5.88%39.68M | 5.88%39.68M | 19.28%37.48M | 19.28%37.48M | 20.85%31.42M | 20.85%31.42M | 52.63%26M | 52.63%26M |
| Net loan | 23.39%5.49B | 23.39%5.49B | -0.79%4.45B | -0.79%4.45B | -6.55%4.49B | -6.55%4.49B | 41.12%4.8B | 41.12%4.8B | 16.51%3.4B | 16.51%3.4B |
| -Gross loan | 23.39%5.49B | 23.39%5.49B | -0.79%4.45B | -0.79%4.45B | -6.55%4.49B | -6.55%4.49B | 41.12%4.8B | 41.12%4.8B | 16.51%3.4B | 16.51%3.4B |
| Receivables | 16.32%15.2M | 16.32%15.2M | -13.45%13.07M | -13.45%13.07M | 28.32%15.1M | 28.32%15.1M | 108.43%11.77M | 108.43%11.77M | 3.65%5.65M | 3.65%5.65M |
| -Accounts receivable | 16.32%15.2M | 16.32%15.2M | -13.45%13.07M | -13.45%13.07M | 28.32%15.1M | 28.32%15.1M | 108.43%11.77M | 108.43%11.77M | 3.65%5.65M | 3.65%5.65M |
| Net PPE | -16.19%4.5M | -16.19%4.5M | -25.45%5.37M | -25.45%5.37M | 20.09%7.2M | 20.09%7.2M | 5.73%6M | 5.73%6M | -16.94%5.67M | -16.94%5.67M |
| -Gross PPE | -16.19%4.5M | -16.19%4.5M | -25.45%5.37M | -25.45%5.37M | 20.09%7.2M | 20.09%7.2M | 5.73%6M | 5.73%6M | -16.94%5.67M | -16.94%5.67M |
| Goodwill and other intangible assets | -2.18%105.5M | -2.18%105.5M | 13.24%107.86M | 13.24%107.86M | 2.76%95.25M | 2.76%95.25M | 875.10%92.69M | 875.10%92.69M | 186.50%9.51M | 186.50%9.51M |
| -Goodwill | 0.03%61.1M | 0.03%61.1M | 0.00%61.08M | 0.00%61.08M | 0.55%61.08M | 0.55%61.08M | --60.75M | --60.75M | ---- | ---- |
| -Other intangible assets | -5.08%44.4M | -5.08%44.4M | 36.90%46.77M | 36.90%46.77M | 6.95%34.17M | 6.95%34.17M | 236.05%31.95M | 236.05%31.95M | 186.50%9.51M | 186.50%9.51M |
| Deferred assets | ---- | ---- | -29.73%104K | -29.73%104K | -91.32%148K | -91.32%148K | --1.71M | --1.71M | ---- | ---- |
| Other assets | 3.42%1.18B | 3.42%1.18B | -0.19%1.14B | -0.19%1.14B | -0.79%1.14B | -0.79%1.14B | 9.33%1.15B | 9.33%1.15B | 7.80%1.05B | 7.80%1.05B |
| Total assets | 18.24%7.07B | 18.24%7.07B | -0.46%5.98B | -0.46%5.98B | -5.63%6B | -5.63%6B | 34.20%6.36B | 34.20%6.36B | 15.94%4.74B | 15.94%4.74B |
| Liabilities | ||||||||||
| Current debt and capital lease obligation | 22.90%5.62B | 22.90%5.62B | -0.60%4.57B | -0.60%4.57B | -7.20%4.6B | -7.20%4.6B | 43.08%4.95B | 43.08%4.95B | 18.55%3.46B | 18.55%3.46B |
| -Current debt | 22.90%5.62B | 22.90%5.62B | -0.60%4.57B | -0.60%4.57B | -7.20%4.6B | -7.20%4.6B | 43.08%4.95B | 43.08%4.95B | 18.55%3.46B | 18.55%3.46B |
| Derivative product liabilities | ---- | ---- | -46.58%11.75M | -46.58%11.75M | 9.02%22M | 9.02%22M | --20.18M | --20.18M | ---- | ---- |
| Payables | 3.27%1.19B | 3.27%1.19B | 0.30%1.15B | 0.30%1.15B | 0.61%1.15B | 0.61%1.15B | 9.84%1.14B | 9.84%1.14B | 8.99%1.04B | 8.99%1.04B |
| -Accounts payable | 3.27%1.19B | 3.27%1.19B | 0.30%1.15B | 0.30%1.15B | 0.61%1.15B | 0.61%1.15B | 9.84%1.14B | 9.84%1.14B | 8.99%1.04B | 8.99%1.04B |
| Current provisions | 42.33%2.3M | 42.33%2.3M | -12.65%1.62M | -12.65%1.62M | -32.21%1.85M | -32.21%1.85M | -17.97%2.73M | -17.97%2.73M | 19.38%3.33M | 19.38%3.33M |
| Current deferred liabilities | -90.16%2.4M | -90.16%2.4M | -6.08%24.39M | -6.08%24.39M | -0.44%25.97M | -0.44%25.97M | 24.40%26.08M | 24.40%26.08M | -18.75%20.96M | -18.75%20.96M |
| Employee benefits | 9.54%7.5M | 9.54%7.5M | 7.14%6.85M | 7.14%6.85M | -11.27%6.39M | -11.27%6.39M | 14.64%7.2M | 14.64%7.2M | 20.97%6.28M | 20.97%6.28M |
| Non current deferred liabilities | --23.2M | --23.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other liabilities | 1.10%6.6M | 1.10%6.6M | 14.23%6.53M | 14.23%6.53M | -17.27%5.72M | -17.27%5.72M | -20.42%6.91M | -20.42%6.91M | 54.49%8.68M | 54.49%8.68M |
| Total liabilities | 18.63%6.85B | 18.63%6.85B | -0.60%5.77B | -0.60%5.77B | -5.70%5.81B | -5.70%5.81B | 35.64%6.16B | 35.64%6.16B | 16.04%4.54B | 16.04%4.54B |
| Shareholders'equity | ||||||||||
| Share capital | -0.02%102.1M | -0.02%102.1M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | -0.03%102.13M | -0.03%102.13M |
| -common stock | -0.02%102.1M | -0.02%102.1M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | 0.00%102.13M | -0.03%102.13M | -0.03%102.13M |
| Retained earnings | 14.64%111.1M | 14.64%111.1M | 7.84%96.91M | 7.84%96.91M | -6.72%89.87M | -6.72%89.87M | 0.02%96.34M | 0.02%96.34M | 31.10%96.31M | 31.10%96.31M |
| Gains losses not affecting retained earnings | 292.97%8.9M | 292.97%8.9M | 64.33%-4.61M | 64.33%-4.61M | 8.56%-12.93M | 8.56%-12.93M | -411.29%-14.14M | -411.29%-14.14M | 75.41%4.54M | 75.41%4.54M |
| Total stockholders'equity | 14.24%222.1M | 14.24%222.1M | 8.58%194.42M | 8.58%194.42M | -2.85%179.06M | -2.85%179.06M | -9.19%184.32M | -9.19%184.32M | 13.90%202.98M | 13.90%202.98M |
| Noncontrolling interests | ---- | ---- | -39.03%12.63M | -39.03%12.63M | -1.91%20.71M | -1.91%20.71M | --21.12M | --21.12M | ---- | ---- |
| Total equity | 7.27%222.1M | 7.27%222.1M | 3.64%207.05M | 3.64%207.05M | -2.76%199.77M | -2.76%199.77M | 1.21%205.44M | 1.21%205.44M | 13.90%202.98M | 13.90%202.98M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |